Vav3, a GEF for RhoA, Plays a Critical Role under High Glucose Conditions
The role of small GTPase molecules is poorly understood under high glucose conditions. We analyzed the expression pattern of Vav3 in skeletal muscle C2C12 cells under high glucose culture condition with reverse transcription-polymerase chain reaction and Western blot analysis. We also measured gluco...
Saved in:
Published in | Endocrinology and metabolism (Seoul) Vol. 29; no. 3; pp. 363 - 370 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
Korean Endocrine Society
01.09.2014
대한내분비학회 |
Subjects | |
Online Access | Get full text |
ISSN | 2093-596X 2093-5978 |
DOI | 10.3803/EnM.2014.29.3.363 |
Cover
Abstract | The role of small GTPase molecules is poorly understood under high glucose conditions.
We analyzed the expression pattern of Vav3 in skeletal muscle C2C12 cells under high glucose culture condition with reverse transcription-polymerase chain reaction and Western blot analysis. We also measured glucose uptake using isotope-labelled glucose.
We showed that expression of Vav3 (a guanine nucleotide exchange factor for RhoA) increased. mRNA and protein levels in skeletal muscle C2C12 cells under high glucose conditions. The AMP-activated protein kinase (AMPK) activator AMPK agonist 5-aminoimidazole-4-carboxy-amide-1-d-ribofuranoside (AICAR) suppressed high glucose-induced Vav3 induction. In addition, exposure of cells to high glucose concentration increased the phosphorylation of PAK-1, a molecule downstream of RhoA. The phosphorylation of paxillin, a downstream molecule of PAK-1, was also increased by exposure to high glucose. Phosphorylation of these molecules was not observed in the presence of AICAR, indicating that AMPK is involved in the RhoA signal pathway under high glucose conditions. Knock down of Vav3 enhances metformin-mediated glucose uptake. Inhibition of AMPK blocked the increases of Vav3 knock down-induced glucose uptake. Metformin-mediated Glut4 translocation was also increased by Vav3 knock-down, suggesting that Vav3 is involved in metformin-mediated glucose uptake.
These results demonstrate that Vav3 is involved in the process of metformin-mediated glucose regulation. |
---|---|
AbstractList | The role of small GTPase molecules is poorly understood under high glucose conditions.BACKGROUNDThe role of small GTPase molecules is poorly understood under high glucose conditions.We analyzed the expression pattern of Vav3 in skeletal muscle C2C12 cells under high glucose culture condition with reverse transcription-polymerase chain reaction and Western blot analysis. We also measured glucose uptake using isotope-labelled glucose.METHODSWe analyzed the expression pattern of Vav3 in skeletal muscle C2C12 cells under high glucose culture condition with reverse transcription-polymerase chain reaction and Western blot analysis. We also measured glucose uptake using isotope-labelled glucose.We showed that expression of Vav3 (a guanine nucleotide exchange factor for RhoA) increased. mRNA and protein levels in skeletal muscle C2C12 cells under high glucose conditions. The AMP-activated protein kinase (AMPK) activator AMPK agonist 5-aminoimidazole-4-carboxy-amide-1-d-ribofuranoside (AICAR) suppressed high glucose-induced Vav3 induction. In addition, exposure of cells to high glucose concentration increased the phosphorylation of PAK-1, a molecule downstream of RhoA. The phosphorylation of paxillin, a downstream molecule of PAK-1, was also increased by exposure to high glucose. Phosphorylation of these molecules was not observed in the presence of AICAR, indicating that AMPK is involved in the RhoA signal pathway under high glucose conditions. Knock down of Vav3 enhances metformin-mediated glucose uptake. Inhibition of AMPK blocked the increases of Vav3 knock down-induced glucose uptake. Metformin-mediated Glut4 translocation was also increased by Vav3 knock-down, suggesting that Vav3 is involved in metformin-mediated glucose uptake.RESULTSWe showed that expression of Vav3 (a guanine nucleotide exchange factor for RhoA) increased. mRNA and protein levels in skeletal muscle C2C12 cells under high glucose conditions. The AMP-activated protein kinase (AMPK) activator AMPK agonist 5-aminoimidazole-4-carboxy-amide-1-d-ribofuranoside (AICAR) suppressed high glucose-induced Vav3 induction. In addition, exposure of cells to high glucose concentration increased the phosphorylation of PAK-1, a molecule downstream of RhoA. The phosphorylation of paxillin, a downstream molecule of PAK-1, was also increased by exposure to high glucose. Phosphorylation of these molecules was not observed in the presence of AICAR, indicating that AMPK is involved in the RhoA signal pathway under high glucose conditions. Knock down of Vav3 enhances metformin-mediated glucose uptake. Inhibition of AMPK blocked the increases of Vav3 knock down-induced glucose uptake. Metformin-mediated Glut4 translocation was also increased by Vav3 knock-down, suggesting that Vav3 is involved in metformin-mediated glucose uptake.These results demonstrate that Vav3 is involved in the process of metformin-mediated glucose regulation.CONCLUSIONThese results demonstrate that Vav3 is involved in the process of metformin-mediated glucose regulation. Background: The role of small GTPase molecules is poorly understood under high glucose conditions. Methods: We analyzed the expression pattern of Vav3 in skeletal muscle C2C12 cells under high glucose culture condition with reverse transcription-polymerase chain reaction and Western blot analysis. We also measured glucose uptake using isotope-labelled glucose. Results: We showed that expression of Vav3 (a guanine nucleotide exchange factor for RhoA) increased. mRNA and protein levels in skeletal muscle C2C12 cells under high glucose conditions. The AMP-activated protein kinase (AMPK) activator AMPK agonist 5-aminoimidazole-4-carboxy-amide-1-d-ribofuranoside (AICAR) suppressed high glucose-induced Vav3 induction. In addition, exposure of cells to high glucose concentration increased the phosphorylation of PAK-1, a molecule downstream of RhoA. The phosphorylation of paxillin, a downstream molecule of PAK-1, was also increased by exposure to high glucose. Phosphorylation of these molecules was not observed in the presence of AICAR, indicating that AMPK is involved in the RhoA signal pathway under high glucose conditions. Knock down of Vav3 enhances metformin-mediated glucose uptake. Inhibition of AMPK blocked the increases of Vav3 knock down-induced glucose uptake. Metformin-mediated Glut4 translocation was also increased by Vav3 knock-down, suggesting that Vav3 is involved in metformin-mediated glucose uptake. Conclusion: These results demonstrate that Vav3 is involved in the process of metformin-mediated glucose regulation. KCI Citation Count: 1 The role of small GTPase molecules is poorly understood under high glucose conditions. We analyzed the expression pattern of Vav3 in skeletal muscle C2C12 cells under high glucose culture condition with reverse transcription-polymerase chain reaction and Western blot analysis. We also measured glucose uptake using isotope-labelled glucose. We showed that expression of Vav3 (a guanine nucleotide exchange factor for RhoA) increased. mRNA and protein levels in skeletal muscle C2C12 cells under high glucose conditions. The AMP-activated protein kinase (AMPK) activator AMPK agonist 5-aminoimidazole-4-carboxy-amide-1-d-ribofuranoside (AICAR) suppressed high glucose-induced Vav3 induction. In addition, exposure of cells to high glucose concentration increased the phosphorylation of PAK-1, a molecule downstream of RhoA. The phosphorylation of paxillin, a downstream molecule of PAK-1, was also increased by exposure to high glucose. Phosphorylation of these molecules was not observed in the presence of AICAR, indicating that AMPK is involved in the RhoA signal pathway under high glucose conditions. Knock down of Vav3 enhances metformin-mediated glucose uptake. Inhibition of AMPK blocked the increases of Vav3 knock down-induced glucose uptake. Metformin-mediated Glut4 translocation was also increased by Vav3 knock-down, suggesting that Vav3 is involved in metformin-mediated glucose uptake. These results demonstrate that Vav3 is involved in the process of metformin-mediated glucose regulation. BackgroundThe role of small GTPase molecules is poorly understood under high glucose conditions.MethodsWe analyzed the expression pattern of Vav3 in skeletal muscle C2C12 cells under high glucose culture condition with reverse transcription-polymerase chain reaction and Western blot analysis. We also measured glucose uptake using isotope-labelled glucose.ResultsWe showed that expression of Vav3 (a guanine nucleotide exchange factor for RhoA) increased. mRNA and protein levels in skeletal muscle C2C12 cells under high glucose conditions. The AMP-activated protein kinase (AMPK) activator AMPK agonist 5-aminoimidazole-4-carboxy-amide-1-d-ribofuranoside (AICAR) suppressed high glucose-induced Vav3 induction. In addition, exposure of cells to high glucose concentration increased the phosphorylation of PAK-1, a molecule downstream of RhoA. The phosphorylation of paxillin, a downstream molecule of PAK-1, was also increased by exposure to high glucose. Phosphorylation of these molecules was not observed in the presence of AICAR, indicating that AMPK is involved in the RhoA signal pathway under high glucose conditions. Knock down of Vav3 enhances metformin-mediated glucose uptake. Inhibition of AMPK blocked the increases of Vav3 knock down-induced glucose uptake. Metformin-mediated Glut4 translocation was also increased by Vav3 knock-down, suggesting that Vav3 is involved in metformin-mediated glucose uptake.ConclusionThese results demonstrate that Vav3 is involved in the process of metformin-mediated glucose regulation. |
Author | Kim, Hyeon Soo Kim, Ji Hae Lee, Jung Ok Choi, Jong-Il Lee, Soo Kyung Kim, Su Jin Moon, Ji Wook Sha, Jie Lee, Hye Jeong Kim, Nami Park, Sun Hwa |
AuthorAffiliation | 1 Department of Anatomy, Korea University College of Medicine, Seoul, Korea 3 Division of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea 2 Bando Hospital, Korea |
AuthorAffiliation_xml | – name: 3 Division of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea – name: 1 Department of Anatomy, Korea University College of Medicine, Seoul, Korea – name: 2 Bando Hospital, Korea |
Author_xml | – sequence: 1 givenname: Jie surname: Sha fullname: Sha, Jie organization: Department of Anatomy, Korea University College of Medicine, Seoul, Korea – sequence: 3 givenname: Jung Ok surname: Lee fullname: Lee, Jung Ok organization: Department of Anatomy, Korea University College of Medicine, Seoul, Korea – sequence: 4 givenname: Nami surname: Kim fullname: Kim, Nami organization: Department of Anatomy, Korea University College of Medicine, Seoul, Korea – sequence: 5 givenname: Soo Kyung surname: Lee fullname: Lee, Soo Kyung organization: Department of Anatomy, Korea University College of Medicine, Seoul, Korea – sequence: 6 givenname: Ji Hae surname: Kim fullname: Kim, Ji Hae organization: Department of Anatomy, Korea University College of Medicine, Seoul, Korea – sequence: 7 givenname: Ji Wook surname: Moon fullname: Moon, Ji Wook organization: Department of Anatomy, Korea University College of Medicine, Seoul, Korea – sequence: 8 givenname: Su Jin surname: Kim fullname: Kim, Su Jin organization: Department of Anatomy, Korea University College of Medicine, Seoul, Korea – sequence: 9 givenname: Hye Jeong surname: Lee fullname: Lee, Hye Jeong organization: Department of Anatomy, Korea University College of Medicine, Seoul, Korea – sequence: 10 givenname: Jong-Il surname: Choi fullname: Choi, Jong-Il organization: Division of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea – sequence: 11 givenname: Sun Hwa surname: Park fullname: Park, Sun Hwa organization: Department of Anatomy, Korea University College of Medicine, Seoul, Korea – sequence: 12 givenname: Hyeon Soo surname: Kim fullname: Kim, Hyeon Soo organization: Department of Anatomy, Korea University College of Medicine, Seoul, Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25309796$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001920407$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNp1Uk1rGzEQFSWlSd38gF7KHnuIt_rY1UqXgjGOY0hpMWnpTWj1YSuRJUfyBvLvK9tN2hQqBDOM3ryZ0by34CTEYAB4j2BNGCSfZuFLjSFqasxrUhNKXoEzDDkZt7xjJ88-_XkKznO-heUw1iCM3oBT3BLIO07PwOKHfCAXlazms8vKxlQt13FyUX3z8jGX6DS5nVPSV8voTTUEbVJ15Vbrau4HFbOppjHoAokhvwOvrfTZnP-2I_D9cnYzvRpff50vppPrsWoQIWPdyNZCbUzHMIaqsajVHPGuJZrInlKiMOlNzzppOeyZlFpjamQPO0MpxZqMwMcjb0hW3CknonQHu4riLonJ8mYhOtrwMuMILI5QHeWt2Ca3kenxgD8EYloJmcp83gikKSS90khB3rRWMYsVU6ZD5de0paZwfT5ybYd-Y7QyYZekf0H68iW4dWnpQTSIY4bJn763Kd4PJu_ExmVlvJfBxCELRFG5jHNWoB_-rvVc5GltBdAdASrFnJOxQrmd3K-hlHZeICj2GhFFI2KvEYG5IKJopGSifzKfyP-f8wvtY7y3 |
CitedBy_id | crossref_primary_10_3390_cells10040915 crossref_primary_10_1038_srep41875 crossref_primary_10_1016_j_bcp_2022_115321 crossref_primary_10_3803_EnM_2015_30_1_47 crossref_primary_10_3389_fncel_2021_661612 crossref_primary_10_1016_j_apsb_2023_03_018 crossref_primary_10_1016_j_bbadis_2024_167236 |
Cites_doi | 10.1096/fj.09-137380 10.1073/pnas.93.16.8431 10.1128/MCB.20.17.6364-6373.2000 10.1007/s10557-008-6092-0 10.1128/MCB.20.5.1461-1477.2000 10.1016/j.ejphar.2009.09.003 10.1016/j.metabol.2007.06.005 10.1210/me.2003-0294 10.1016/S0960-9822(07)00559-3 10.1152/ajpcell.00269.2006 10.1001/archinternmed.2009.20 10.2337/diabetes.51.10.2886 10.1126/science.279.5350.558 10.1016/S0024-3205(01)01225-5 10.1111/j.1742-1241.2004.00318.x 10.1152/ajpendo.00167.2001 10.1042/0264-6021:3480083 10.2337/db06-0823 10.1128/MCB.11.4.1912 10.1111/j.1469-1809.1995.tb01603.x 10.1042/BC20070160 10.1074/jbc.271.13.7544 10.1152/ajpendo.00254.2001 10.1016/j.cell.2009.03.016 10.1016/S0092-8674(04)00003-0 10.1161/01.RES.80.4.482 10.1111/j.1432-1033.1997.00259.x 10.1073/pnas.252625599 10.1096/fasebj.9.7.7737463 10.1002/j.1460-2075.1989.tb08354.x |
ContentType | Journal Article |
Copyright | Copyright © 2014 Korean Endocrine Society 2014 |
Copyright_xml | – notice: Copyright © 2014 Korean Endocrine Society 2014 |
DBID | AAYXX CITATION NPM 7X8 5PM DOA ACYCR |
DOI | 10.3803/EnM.2014.29.3.363 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals Korean Citation Index |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2093-5978 |
EndPage | 370 |
ExternalDocumentID | oai_kci_go_kr_ARTI_764925 oai_doaj_org_article_1d603bcd1c0945fc8f2c8ce71008df6e PMC4192823 25309796 10_3803_EnM_2014_29_3_363 |
Genre | Journal Article |
GrantInformation_xml | – fundername: National Research Foundation of Korea grantid: NRF-2013R1A2A2A05004796 |
GroupedDBID | 5-W 53G 5VS 8JR 8XY AAYXX ABDBF ACUHS ADBBV ADRAZ ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EF. GROUPED_DOAJ HYE HZB IPNFZ KQ8 M48 OK1 PGMZT RIG RPM NPM 7X8 5PM ACYCR |
ID | FETCH-LOGICAL-c4133-d4a5f0dee78220c4f15d919753d3ab663c23beb87af90b8aadd26eab07e6662d3 |
IEDL.DBID | M48 |
ISSN | 2093-596X |
IngestDate | Tue Nov 21 21:43:00 EST 2023 Wed Aug 27 01:28:52 EDT 2025 Thu Aug 21 18:12:07 EDT 2025 Thu Jul 10 23:05:48 EDT 2025 Wed Feb 19 01:55:45 EST 2025 Tue Jul 01 01:37:45 EDT 2025 Thu Apr 24 23:07:21 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Vav3 AMP-activated protein kinases Diabetes Metformin High glucose |
Language | English |
License | http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4133-d4a5f0dee78220c4f15d919753d3ab663c23beb87af90b8aadd26eab07e6662d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors contributed equally to this work. G704-001505.2014.29.3.020 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3803/EnM.2014.29.3.363 |
PMID | 25309796 |
PQID | 1611618998 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_764925 doaj_primary_oai_doaj_org_article_1d603bcd1c0945fc8f2c8ce71008df6e pubmedcentral_primary_oai_pubmedcentral_nih_gov_4192823 proquest_miscellaneous_1611618998 pubmed_primary_25309796 crossref_citationtrail_10_3803_EnM_2014_29_3_363 crossref_primary_10_3803_EnM_2014_29_3_363 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20140901 |
PublicationDateYYYYMMDD | 2014-09-01 |
PublicationDate_xml | – month: 9 year: 2014 text: 20140901 day: 1 |
PublicationDecade | 2010 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | Endocrinology and metabolism (Seoul) |
PublicationTitleAlternate | Endocrinol Metab (Seoul) |
PublicationYear | 2014 |
Publisher | Korean Endocrine Society 대한내분비학회 |
Publisher_xml | – name: Korean Endocrine Society – name: 대한내분비학회 |
References | Hardie (10.3803/EnM.2014.29.3.363_ref13) 1997; 246 Han (10.3803/EnM.2014.29.3.363_ref28) 1998; 279 Henin (10.3803/EnM.2014.29.3.363_ref17) 1995; 9 Katzav (10.3803/EnM.2014.29.3.363_ref33) 1989; 8 Henske (10.3803/EnM.2014.29.3.363_ref36) 1995; 59 Despres (10.3803/EnM.2014.29.3.363_ref2) 2003; 29 Miranti (10.3803/EnM.2014.29.3.363_ref31) 1998; 8 Ju (10.3803/EnM.2014.29.3.363_ref19) 2007; 292 JeBailey (10.3803/EnM.2014.29.3.363_ref24) 2007; 56 Katzav (10.3803/EnM.2014.29.3.363_ref35) 1991; 11 Iglesias (10.3803/EnM.2014.29.3.363_ref20) 2002; 51 Bustelo (10.3803/EnM.2014.29.3.363_ref27) 2000; 20 Zheng (10.3803/EnM.2014.29.3.363_ref32) 1996; 93 Pryor (10.3803/EnM.2014.29.3.363_ref11) 2000; 348 Fisher (10.3803/EnM.2014.29.3.363_ref18) 2002; 282 Wang (10.3803/EnM.2014.29.3.363_ref12) 2007; 38 Ueda (10.3803/EnM.2014.29.3.363_ref25) 2008; 100 Ai (10.3803/EnM.2014.29.3.363_ref15) 2002; 282 Gotoh (10.3803/EnM.2014.29.3.363_ref30) 1997; 8 Borst (10.3803/EnM.2014.29.3.363_ref6) 2001; 69 Zong (10.3803/EnM.2014.29.3.363_ref16) 2002; 99 Moores (10.3803/EnM.2014.29.3.363_ref26) 2000; 20 JeBailey (10.3803/EnM.2014.29.3.363_ref23) 2004; 18 Siegel (10.3803/EnM.2014.29.3.363_ref1) 1999 Ueda (10.3803/EnM.2014.29.3.363_ref22) 2010; 24 Cichowski (10.3803/EnM.2014.29.3.363_ref29) 1996; 271 He (10.3803/EnM.2014.29.3.363_ref8) 2009; 137 Burridge (10.3803/EnM.2014.29.3.363_ref21) 2004; 116 Bailey (10.3803/EnM.2014.29.3.363_ref3) 2004; 58 Yoshida (10.3803/EnM.2014.29.3.363_ref9) 2009; 623 Teranishi (10.3803/EnM.2014.29.3.363_ref7) 2007; 56 Wiernsperger (10.3803/EnM.2014.29.3.363_ref10) 1999; 25 Bailey (10.3803/EnM.2014.29.3.363_ref4) 2008; 22 Adams (10.3803/EnM.2014.29.3.363_ref34) 1992; 7 Makinde (10.3803/EnM.2014.29.3.363_ref14) 1997; 80 Kooy (10.3803/EnM.2014.29.3.363_ref5) 2009; 169 Schuebel (10.3803/EnM.2014.29.3.363_ref37) 1996; 13 12351423 - Diabetes. 2002 Oct;51(10):2886-94 2005887 - Mol Cell Biol. 1991 Apr;11(4):1912-20 11554611 - Life Sci. 2001 Aug 17;69(13):1497-507 14615606 - Mol Endocrinol. 2004 Feb;18(2):359-72 19307526 - Arch Intern Med. 2009 Mar 23;169(6):616-25 9438848 - Science. 1998 Jan 23;279(5350):558-60 16870829 - Am J Physiol Cell Physiol. 2007 Jan;292(1):C564-72 19450513 - Cell. 2009 May 15;137(4):635-46 9843681 - Curr Biol. 1998 Dec 3;8(24):1289-99 9118478 - Circ Res. 1997 Apr;80(4):482-9 10794717 - Biochem J. 2000 May 15;348 Pt 1:83-91 18482007 - Biol Cell. 2008 Nov;100(11):645-57 8710375 - Oncogene. 1996 Jul 18;13(2):363-71 10938113 - Mol Cell Biol. 2000 Sep;20(17):6364-73 17953367 - Sichuan Da Xue Xue Bao Yi Xue Ban. 2007 Sep;38(5):819-21 17884455 - Metabolism. 2007 Oct;56(10):1418-24 2477241 - EMBO J. 1989 Aug;8(8):2283-90 9208914 - Eur J Biochem. 1997 Jun 1;246(2):259-73 8631786 - J Biol Chem. 1996 Mar 29;271(13):7544-50 15529521 - Int J Clin Pract. 2004 Sep;58(9):867-76 11739078 - Am J Physiol Endocrinol Metab. 2002 Jan;282(1):E18-23 18288595 - Cardiovasc Drugs Ther. 2008 Jun;22(3):215-24 8710888 - Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8431-6 14744429 - Cell. 2004 Jan 23;116(2):167-79 19765581 - Eur J Pharmacol. 2009 Nov 25;623(1-3):141-7 17259384 - Diabetes. 2007 Feb;56(2):394-403 9186005 - Cell Growth Differ. 1997 Jun;8(6):721-9 10669724 - Mol Cell Biol. 2000 Mar;20(5):1461-77 12006359 - Am J Physiol Endocrinol Metab. 2002 Jun;282(6):E1291-300 10443322 - Diabetes Metab. 1999 Jun;25(2):110-27 14502101 - Diabetes Metab. 2003 Sep;29(4 Pt 2):6S53-61 20203090 - FASEB J. 2010 Jul;24(7):2254-61 1565462 - Oncogene. 1992 Apr;7(4):611-8 7737463 - FASEB J. 1995 Apr;9(7):541-6 12444247 - Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):15983-7 7762982 - Ann Hum Genet. 1995 Jan;59(Pt 1):25-37 |
References_xml | – volume: 24 start-page: 2254 year: 2010 ident: 10.3803/EnM.2014.29.3.363_ref22 publication-title: FASEB J doi: 10.1096/fj.09-137380 – volume: 93 start-page: 8431 year: 1996 ident: 10.3803/EnM.2014.29.3.363_ref32 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.93.16.8431 – volume: 20 start-page: 6364 year: 2000 ident: 10.3803/EnM.2014.29.3.363_ref26 publication-title: Mol Cell Biol doi: 10.1128/MCB.20.17.6364-6373.2000 – volume: 22 start-page: 215 year: 2008 ident: 10.3803/EnM.2014.29.3.363_ref4 publication-title: Cardiovasc Drugs Ther doi: 10.1007/s10557-008-6092-0 – volume: 20 start-page: 1461 year: 2000 ident: 10.3803/EnM.2014.29.3.363_ref27 publication-title: Mol Cell Biol doi: 10.1128/MCB.20.5.1461-1477.2000 – volume: 623 start-page: 141 year: 2009 ident: 10.3803/EnM.2014.29.3.363_ref9 publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2009.09.003 – volume: 56 start-page: 1418 year: 2007 ident: 10.3803/EnM.2014.29.3.363_ref7 publication-title: Metabolism doi: 10.1016/j.metabol.2007.06.005 – volume: 18 start-page: 359 year: 2004 ident: 10.3803/EnM.2014.29.3.363_ref23 publication-title: Mol Endocrinol doi: 10.1210/me.2003-0294 – volume: 8 start-page: 1289 year: 1998 ident: 10.3803/EnM.2014.29.3.363_ref31 publication-title: Curr Biol doi: 10.1016/S0960-9822(07)00559-3 – volume: 292 start-page: C564 year: 2007 ident: 10.3803/EnM.2014.29.3.363_ref19 publication-title: Am J Physiol Cell Physiol doi: 10.1152/ajpcell.00269.2006 – volume: 169 start-page: 616 year: 2009 ident: 10.3803/EnM.2014.29.3.363_ref5 publication-title: Arch Intern Med doi: 10.1001/archinternmed.2009.20 – volume: 51 start-page: 2886 year: 2002 ident: 10.3803/EnM.2014.29.3.363_ref20 publication-title: Diabetes doi: 10.2337/diabetes.51.10.2886 – volume: 279 start-page: 558 year: 1998 ident: 10.3803/EnM.2014.29.3.363_ref28 publication-title: Science doi: 10.1126/science.279.5350.558 – volume: 25 start-page: 110 year: 1999 ident: 10.3803/EnM.2014.29.3.363_ref10 publication-title: Diabetes Metab – volume: 7 start-page: 611 year: 1992 ident: 10.3803/EnM.2014.29.3.363_ref34 publication-title: Oncogene – volume: 13 start-page: 363 year: 1996 ident: 10.3803/EnM.2014.29.3.363_ref37 publication-title: Oncogene – volume: 69 start-page: 1497 year: 2001 ident: 10.3803/EnM.2014.29.3.363_ref6 publication-title: Life Sci doi: 10.1016/S0024-3205(01)01225-5 – start-page: 637 volume-title: Basic Neurochemistry year: 1999 ident: 10.3803/EnM.2014.29.3.363_ref1 – volume: 8 start-page: 721 year: 1997 ident: 10.3803/EnM.2014.29.3.363_ref30 publication-title: Cell Growth Differ – volume: 58 start-page: 867 year: 2004 ident: 10.3803/EnM.2014.29.3.363_ref3 publication-title: Int J Clin Pract doi: 10.1111/j.1742-1241.2004.00318.x – volume: 282 start-page: E1291 year: 2002 ident: 10.3803/EnM.2014.29.3.363_ref15 publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00167.2001 – volume: 38 start-page: 819 year: 2007 ident: 10.3803/EnM.2014.29.3.363_ref12 publication-title: Sichuan Da Xue Xue Bao Yi Xue Ban – volume: 348 start-page: 83 issue: Pt 1 year: 2000 ident: 10.3803/EnM.2014.29.3.363_ref11 publication-title: Biochem J doi: 10.1042/0264-6021:3480083 – volume: 56 start-page: 394 year: 2007 ident: 10.3803/EnM.2014.29.3.363_ref24 publication-title: Diabetes doi: 10.2337/db06-0823 – volume: 11 start-page: 1912 year: 1991 ident: 10.3803/EnM.2014.29.3.363_ref35 publication-title: Mol Cell Biol doi: 10.1128/MCB.11.4.1912 – volume: 59 start-page: 25 issue: Pt 1 year: 1995 ident: 10.3803/EnM.2014.29.3.363_ref36 publication-title: Ann Hum Genet doi: 10.1111/j.1469-1809.1995.tb01603.x – volume: 100 start-page: 645 year: 2008 ident: 10.3803/EnM.2014.29.3.363_ref25 publication-title: Biol Cell doi: 10.1042/BC20070160 – volume: 271 start-page: 7544 year: 1996 ident: 10.3803/EnM.2014.29.3.363_ref29 publication-title: J Biol Chem doi: 10.1074/jbc.271.13.7544 – volume: 282 start-page: E18 year: 2002 ident: 10.3803/EnM.2014.29.3.363_ref18 publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00254.2001 – volume: 137 start-page: 635 year: 2009 ident: 10.3803/EnM.2014.29.3.363_ref8 publication-title: Cell doi: 10.1016/j.cell.2009.03.016 – volume: 29 start-page: 6S53 issue: 4 Pt 2 year: 2003 ident: 10.3803/EnM.2014.29.3.363_ref2 publication-title: Diabetes Metab – volume: 116 start-page: 167 year: 2004 ident: 10.3803/EnM.2014.29.3.363_ref21 publication-title: Cell doi: 10.1016/S0092-8674(04)00003-0 – volume: 80 start-page: 482 year: 1997 ident: 10.3803/EnM.2014.29.3.363_ref14 publication-title: Circ Res doi: 10.1161/01.RES.80.4.482 – volume: 246 start-page: 259 year: 1997 ident: 10.3803/EnM.2014.29.3.363_ref13 publication-title: Eur J Biochem doi: 10.1111/j.1432-1033.1997.00259.x – volume: 99 start-page: 15983 year: 2002 ident: 10.3803/EnM.2014.29.3.363_ref16 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.252625599 – volume: 9 start-page: 541 year: 1995 ident: 10.3803/EnM.2014.29.3.363_ref17 publication-title: FASEB J doi: 10.1096/fasebj.9.7.7737463 – volume: 8 start-page: 2283 year: 1989 ident: 10.3803/EnM.2014.29.3.363_ref33 publication-title: EMBO J doi: 10.1002/j.1460-2075.1989.tb08354.x – reference: 12006359 - Am J Physiol Endocrinol Metab. 2002 Jun;282(6):E1291-300 – reference: 12351423 - Diabetes. 2002 Oct;51(10):2886-94 – reference: 10938113 - Mol Cell Biol. 2000 Sep;20(17):6364-73 – reference: 1565462 - Oncogene. 1992 Apr;7(4):611-8 – reference: 8710375 - Oncogene. 1996 Jul 18;13(2):363-71 – reference: 7762982 - Ann Hum Genet. 1995 Jan;59(Pt 1):25-37 – reference: 17259384 - Diabetes. 2007 Feb;56(2):394-403 – reference: 10794717 - Biochem J. 2000 May 15;348 Pt 1:83-91 – reference: 12444247 - Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):15983-7 – reference: 14502101 - Diabetes Metab. 2003 Sep;29(4 Pt 2):6S53-61 – reference: 2477241 - EMBO J. 1989 Aug;8(8):2283-90 – reference: 19450513 - Cell. 2009 May 15;137(4):635-46 – reference: 8710888 - Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8431-6 – reference: 14744429 - Cell. 2004 Jan 23;116(2):167-79 – reference: 9208914 - Eur J Biochem. 1997 Jun 1;246(2):259-73 – reference: 9438848 - Science. 1998 Jan 23;279(5350):558-60 – reference: 2005887 - Mol Cell Biol. 1991 Apr;11(4):1912-20 – reference: 9843681 - Curr Biol. 1998 Dec 3;8(24):1289-99 – reference: 19307526 - Arch Intern Med. 2009 Mar 23;169(6):616-25 – reference: 11554611 - Life Sci. 2001 Aug 17;69(13):1497-507 – reference: 20203090 - FASEB J. 2010 Jul;24(7):2254-61 – reference: 9118478 - Circ Res. 1997 Apr;80(4):482-9 – reference: 17884455 - Metabolism. 2007 Oct;56(10):1418-24 – reference: 11739078 - Am J Physiol Endocrinol Metab. 2002 Jan;282(1):E18-23 – reference: 10669724 - Mol Cell Biol. 2000 Mar;20(5):1461-77 – reference: 17953367 - Sichuan Da Xue Xue Bao Yi Xue Ban. 2007 Sep;38(5):819-21 – reference: 15529521 - Int J Clin Pract. 2004 Sep;58(9):867-76 – reference: 9186005 - Cell Growth Differ. 1997 Jun;8(6):721-9 – reference: 14615606 - Mol Endocrinol. 2004 Feb;18(2):359-72 – reference: 7737463 - FASEB J. 1995 Apr;9(7):541-6 – reference: 18482007 - Biol Cell. 2008 Nov;100(11):645-57 – reference: 16870829 - Am J Physiol Cell Physiol. 2007 Jan;292(1):C564-72 – reference: 18288595 - Cardiovasc Drugs Ther. 2008 Jun;22(3):215-24 – reference: 19765581 - Eur J Pharmacol. 2009 Nov 25;623(1-3):141-7 – reference: 8631786 - J Biol Chem. 1996 Mar 29;271(13):7544-50 – reference: 10443322 - Diabetes Metab. 1999 Jun;25(2):110-27 |
SSID | ssj0000884121 |
Score | 1.9863598 |
Snippet | The role of small GTPase molecules is poorly understood under high glucose conditions.
We analyzed the expression pattern of Vav3 in skeletal muscle C2C12... The role of small GTPase molecules is poorly understood under high glucose conditions.BACKGROUNDThe role of small GTPase molecules is poorly understood under... BackgroundThe role of small GTPase molecules is poorly understood under high glucose conditions.MethodsWe analyzed the expression pattern of Vav3 in skeletal... Background: The role of small GTPase molecules is poorly understood under high glucose conditions. Methods: We analyzed the expression pattern of Vav3 in... |
SourceID | nrf doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 363 |
SubjectTerms | AMP-activated protein kinases Diabetes High glucose Metformin Original Vav3 내과학 |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3dSxwxEA_iU19EadXVtqTgk7hnNtl87KOVOz9AEdFybyGbjyoeu-XUQv_7zuzeHXeltC--7EI2gezMJDPDzPyGkANwcHwtpM514WRehhRy56qYFynx4HzpGcMC56trdX5fXo7leKnVF-aE9fDAPeGOi6CYqH0oPDgimHCUuDc-dqA0IamIty-osSVnqruDjSmLruiKg8uey0qN-5CmMEwcD5srTOoqB7waiIFQYkUpddj9oGqaafqb2fln9uSSOhptko2ZHUlP-v1vkbXYvCcX39xPcUQdPRuOKFij9PahPTmiNxP36xlG520N6G07iRSrx6YU8zzoWZ-3Tk9bDGCjIH4g96Ph3el5PuuVkHtQQyIPpZOJhRhR4zNfpkKGqsCq2SBcDWaF56KOtdEuVaw2Dq41rqKrmY7gwPAgtsl60zZxl1BpUvLcBxUQmoZr40MQLHKumfTwzAibE8v6GZA49rOYWHAokL4W6GuRvpZXVligb0YOF0t-9Cga_5r8FTmwmIgA2N0AiIWdiYX9n1hk5Avwzz75x249vr-39mlqwU24sFohJiPMmXPXwqHCSIlrYvv6bMEMxkYC4IpmZKfn9mI7XApW6UplRK_Iwcp-V780jw8dcDdG3A0Xe2_xg_vkHVKtT3f7SNZfpq_xE9hHL_Xn7ij8BsFeCj0 priority: 102 providerName: Directory of Open Access Journals |
Title | Vav3, a GEF for RhoA, Plays a Critical Role under High Glucose Conditions |
URI | https://www.ncbi.nlm.nih.gov/pubmed/25309796 https://www.proquest.com/docview/1611618998 https://pubmed.ncbi.nlm.nih.gov/PMC4192823 https://doaj.org/article/1d603bcd1c0945fc8f2c8ce71008df6e https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001920407 |
Volume | 29 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Endocrinology and Metabolism, 2014, 29(3), , pp.363-370 |
journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 2093-5978 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000884121 issn: 2093-596X databaseCode: KQ8 dateStart: 20130101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2093-5978 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000884121 issn: 2093-596X databaseCode: DOA dateStart: 20050101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVEBS databaseName: EBSCOhost Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 2093-5978 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000884121 issn: 2093-596X databaseCode: ABDBF dateStart: 20120901 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 2093-5978 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000884121 issn: 2093-596X databaseCode: DIK dateStart: 20100101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVERR databaseName: KoreaMed Open Access customDbUrl: eissn: 2093-5978 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000884121 issn: 2093-596X databaseCode: 5-W dateStart: 20100101 isFulltext: true titleUrlDefault: https://koreamed.org/journals providerName: Korean Association of Medical Journal Editors – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 2093-5978 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000884121 issn: 2093-596X databaseCode: RPM dateStart: 20130101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 2093-5978 dateEnd: 20250831 omitProxy: true ssIdentifier: ssj0000884121 issn: 2093-596X databaseCode: M48 dateStart: 20130301 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9swEBdd97KXsbEv76NosKdRZbJkWfbDGF1J2g4yRllG3oSsj7Y02K3TjvW_353thGWEsRcbZMkWdyfd_XynO0LeAcBxlVSa6dQqlvnombVlYGmMwluXOc7xgPP0a348y77M1XyHrLznAwGXW6Ed1pOatYvRr-u7T7DgPyLiLLj8MK6nGKOVjUQ5kiMJC-bqmmFdKfS_DkU27pH7oKsEyv10AADdXl0U0IqoTAC0Z6rM573rc_uLN5RXl-MfVFLdxm3m6d9Rln-orckj8nCwN-lBLyCPyU6on5CTH_an3KeWHo0nFKxWenreHOzTbwt7t4TWVfkDetosAsVTZi3FeBB61Me308MGHd0osE_JbDL-fnjMhpoKzIG6ksxnVkXuQ0DLgLsspsqXKZ6u9dJWYH44IatQFdrGkleFhe1P5MFWXAcAOsLLZ2S3burwglBVxOiE87nHFDZCF857yYMQmisH14TwFbGMGxKOY92LhQHggfQ1QF-D9DWiNNIAfRPyfj3kqs-28a_On5ED646YKLtraNozM6w7k_qcy8r51AGOxXi1KFzhQpfTyMc8JOQt8M9cuotuPN7PGnPZGoATJ0bnmLsR-qy4a2DxoUfF1qG5XRowl7HgAEDWhDzvub2ejlCSl7rME6I35GBjvptP6ovzLsE3euYLIV_-x3dfkQdIlD7q7TXZvWlvwxswk26qve73wl4n778BV7QOmg |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Vav3%2C+a+GEF+for+RhoA%2C+Plays+a+Critical+Role+under+High+Glucose+Conditions&rft.jtitle=Endocrinology+and+metabolism+%28Seoul%29&rft.au=Sha%2C+Jie&rft.au=Na%2C+Jungsik&rft.au=Lee%2C+Jung+Ok&rft.au=Kim%2C+Nami&rft.date=2014-09-01&rft.issn=2093-596X&rft.volume=29&rft.issue=3&rft.spage=363&rft_id=info:doi/10.3803%2FEnM.2014.29.3.363&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2093-596X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2093-596X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2093-596X&client=summon |